(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(-0.07%) $80.00
(0.46%) $2.64
(0.10%) $2 419.80
(1.65%) $31.78
(0.43%) $1 094.70
(-0.03%) $0.920
(-0.02%) $10.69
(-0.21%) $0.788
(0.02%) $90.89
Quarter results tomorrow
(bmo 2024-05-20)
Expected move: +/- 14.57%
-4.01% $ 2.63
@ $3.52
Emitido: 8 feb 2024 @ 14:59
Retorno: -25.28%
Señal anterior: feb 7 - 15:44
Señal anterior:
Retorno: 2.03 %
Live Chart Being Loaded With Signals
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers...
Stats | |
---|---|
Volumen de hoy | 375 785 |
Volumen promedio | 307 798 |
Capitalización de mercado | 100.64M |
EPS | $0 ( 2024-05-13 ) |
Próxima fecha de ganancias | ( $-0.570 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.660 |
ATR14 | $0.0230 (0.87%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-10 | Gilead Sciences, Inc. | Sell | 0 | Common Stock |
2024-01-29 | Mashiach Nissim | Buy | 25 000 | Stock Option (Right to Buy) |
2024-01-29 | Dietz Thomas John | Buy | 30 000 | Stock Option (Right to Buy) |
2024-01-29 | Schilsky Richard | Buy | 25 000 | Stock Option (Right to Buy) |
2024-01-29 | Granfield Christine | Buy | 85 000 | Employee Stock Option (Right to Buy) |
INSIDER POWER |
---|
66.43 |
Last 95 transactions |
Buy: 10 825 606 | Sell: 1 768 106 |
Volumen Correlación
Leap Therapeutics Inc Correlación
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Leap Therapeutics Inc Correlación - Moneda/Commodity
Leap Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-427 000 (0.00 %) |
EPS: | $-3.98 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-427 000 (0.00 %) |
EPS: | $-3.98 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-415 000 (0.00 %) |
EPS: | $-4.82 |
FY | 2021 |
Ingresos: | $1.50M |
Beneficio Bruto: | $1.50M (100.00 %) |
EPS: | $-0.470 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Leap Therapeutics Inc
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico